Plasma Derived Manufacturer: A Partner Case Study
A Proven Buy-and-Bill Growth Partnership in Ambulatory Infusion
Executive Summary
For manufacturers with buy-and-bill infusion therapies, success depends on more than securing contracts. It requires placing therapies in the optimal site of care—one that balances patient experience, provider engagement, and economic sustainability.
Infinity Infusion Solutions (IIS) believes ambulatory infusion centers (AICs) and provider-owned or managed infusion clinics are the optimal settings for infusion care. Through its partnership with a plasma-derived manufacturer, IIS demonstrated a repeatable, scalable model for accelerating the adoption of buy-and-bill infusion therapies—particularly in neurology and immunology—while outperforming traditional GPO, wholesaler, and distributor-driven approaches.
In 2024, this manufacturer–IIS partnership delivered measurable growth, expanded market penetration, and reactivated underutilized infusion sites, establishing IIS as the most successful partnership in the alternate-site infusion space.
The Manufacturer Challenge
Manufacturers of buy-and-bill infusion therapies face increasing pressure to move care out of high-cost hospital outpatient departments while maintaining control, visibility, and consistent product adoption.
Common challenges include: - Fragmented ambulatory infusion and provider clinic landscape - Limited awareness and confidence among independent infusion centers - Dormant or underutilized contracted accounts - Minimal pull-through after contracting - Lack of actionable, site-level market feedback
While hospitals and homecare each play important roles, they are not always the optimal setting for every patient or therapy. Ambulatory infusion centers and provider-owned clinics represent a critical middle ground—when properly activated.
Why Site of Care Matters
IIS is purpose-built around the belief that ambulatory infusion centers and provider-owned infusion clinics are the optimal sites of care for many buy-and-bill therapies.
The Infinity Infusion Solutions Model
Infinity Infusion Solutions partners with manufacturers to drive real-world adoption in ambulatory and provider-based infusion settings through a high-touch, performance-driven model.
The IIS Commercial Activation Model
Direct Provider Access
Engagement with a national network of more than 2,600 infusion centers and clinics, with strong representation in neurology and immunology.
Education & Operational Support
Product education paired with reimbursement, ordering, and operational guidance tailored to buyand-bill workflows.
Account Activation
Identification and reactivation of dormant accounts, resolution of affiliation gaps, and targeted focus on high-growth opportunities.
Performance Visibility
Ongoing tracking of account-level performance and actionable market insights delivered to manufacturer partners.
This model moves beyond transactional contracting to influence where—and how—infusion therapies are delivered.
Case Study: Plasma-Derived Manufacturer Partnership Results
This specific plasma-derived manufacturer partnered with Infinity Infusion Solutions to expand market penetration of its infusion portfolio across ambulatory infusion centers and provider-owned clinics.
Measurable Outcomes
44% increase in total purchasing accounts
Approximately 90% of new purchasing accounts are introduced through IIS
Consistent quarter-over-quarter volume growth across leading neurology and immunology-focused infusion centers
Successful reactivation of previously dormant or underutilized accounts
This partnership became the manufacturer's successful engagement in the alternate-site infusion space — outperforming national GPO, wholesaler, and distributor partnerships.
Representative Site Growth
Following IIS engagement, multiple high-performing infusion centers demonstrated sustained quarterover-quarter growth.
These sites highlight IIS’s ability to influence adoption at the point of care and drive consistent buy-and-bill utilization within ambulatory and provider-owned settings.
Market Validation
Manufacturer Perspective
“Manufacturers rely heavily on channel partners to extend reach and communicate information to customers. At our company, we have found Infinity Infusion Solutions to be a strong strategic partner offering valuable market insights, trusted customer relationships, and the ability to support and drive our priority initiatives.”
— Plasma Derived Manufacturer
Additional manufacturer partners have echoed similar experiences, reinforcing that the IIS model delivers consistent commercial value across multiple portfolios.
Provider Perspective
Infusion center members report increased confidence, operational clarity, and improved access to therapies through their engagement with IIS—underscoring the trust IIS has built at the site-of-care level.
Why This Model Works for Other Manufacturers
The case study demonstrates a model that is highly transferable for manufacturers with buy-and-bill infusion therapies, including:
Neurology and immunology biologics
Biosimilars - Pipeline infusion therapies
Products seeking site-of-care optimization
Manufacturers benefit from faster adoption, greater visibility, and sustained pull-through in ambulatory and provider-owned infusion settings.
Conclusion
Infinity Infusion Solutions is a proven partner for manufacturers with buy-and-bill infusion therapies. By focusing on ambulatory infusion centers and provider-owned or managed clinics as the optimal sites of care, IIS delivers measurable growth, trusted provider engagement, and repeatable commercial success.
The partnership illustrates how manufacturers can move beyond traditional channels to achieve scalable adoption where infusion therapies perform best.
Call to Action
Partner with Infinity Infusion Solutions to accelerate the adoption of your buy-and-bill infusion therapies in ambulatory and provider-based settings.
Proven partner. Proven model. Optimal site of care.
